Deutsche Bank Aktiengesellschaft has reduced its price target for Clorox (NYSE:CLX) from $101.00 to $100.00, maintaining a "hold" rating due to a potential 3.3% downside. This follows other analyst downgrades and a recent EPS miss where Clorox reported $1.39 against expected $1.43, with revenue declining 0.8% year-over-year. The consensus among analysts is a "Reduce" rating with an average price target of $113.87, based on mixed sentiment with only one "Buy" rating among major firms.

Wells Fargo & Company has raised its price target for Duke Energy (NYSE:DUK) to $136.00 from $135.00, maintaining an "equal weight" rating and suggesting a 6.35% upside. This comes amid mixed analyst ratings, with Duke Energy recently exceeding earnings estimates. Notably, there have been recent insider sales by the CEO and SVP.

BMO Capital Markets increased its price target for The Goldman Sachs Group (NYSE:GS) to $972 from $905, maintaining a "market perform" rating and suggesting a modest 4.3% upside from current levels. Analyst sentiment for GS is mixed, with a consensus "Hold" rating amid an average price target of $924.14. Despite a strong Q1 earnings beat, several insiders have sold shares totaling approximately $46.2 million in the last three months, though institutional investors have largely increased their positions.

AnaptysBio, Inc. has successfully spun off its biopharma operations into First Tracks Biotherapeutics, Inc., transforming itself into a royalty management entity. The company will now focus on financial collaborations for Jemperli and imsidolimab, operating virtually with minimal expenses and a strong cash position. This restructuring has led to a significant return for ANAB shareholders, with First Tracks Bio independently trading under the symbol TRAX on Nasdaq.

TD Cowen analyst Itay Michaeli has increased the price target for Autoliv, Inc. (NYSE: ALV) to $150.00 from $147.00, while maintaining their rating. This adjustment follows what the analyst describes as a "Reassuring Q1/Guide," which reportedly supports a bullish outlook for the company's stock. The full details of this analysis are available to premium subscribers.

Abacus Global Management (NYSE:ABX) is set to participate for the first time in the 2026 Milken Institute Global Conference. CEO Jay Jackson will join a panel to discuss key trends in private wealth and financial security, including aging populations, wealth transfer, and alternative investments. Other senior executives will also be present to meet with investors during the conference.

DaVita Inc. operates a dominant dialysis network in the U.S., serving over 200,000 patients annually and commanding about 37% of the market. Its business model, primarily reliant on government reimbursements, offers defensive healthcare exposure due to the non-discretionary nature of kidney care. While facing risks from reimbursement cuts and labor shortages, DaVita's scale and integrated care approach provide a competitive moat, making it a stable option for investors in the essential medical services sector.

Morgan Stanley has an "overweight" rating on TC Energy, considering it an attractive and low-risk option for investors seeking exposure to nuclear energy. The investment bank highlights TC Energy's 48% interest in Bruce Power, one of the world's largest nuclear facilities, and its initiatives to expand nuclear capabilities through the Major Component Replacement program and the Bruce C project. Despite being overlooked by some investors who gravitate towards more speculative plays, Morgan Stanley views TC Energy as a high-quality, low-risk way to participate in the growing nuclear power sector.

U.S. Bancorp (USB) reported strong Q1 earnings, with net income up 14% and diluted EPS up 15%, driven by revenue growth in net interest and fee income. The bank's stock rose 2.61% on the news. Key catalysts for future growth include a new credit card partnership with Amazon, expected to add significant loan and client numbers, and the acquisition of BTIG, an investment banking firm, which will boost fee revenue.

Tractor Supply Company (TSCO) is set to release its first-quarter earnings, with investors closely watching for signs of improvement in comparable sales, after the stock dipped near its 52-week low. Analysts anticipate modest revenue and EPS growth, but concerns persist about the company's ability to meet or exceed Street expectations for comparable store sales, especially given recent declines in EPS estimates and pressure from commodity inflation and competition in rural markets. Investors will be looking for management commentary on sales momentum and guidance to determine if recent weakness is temporary or indicative of a longer period of muted growth.